Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9236 |
High Similarity |
NPD3818 |
Discontinued |
0.8897 |
High Similarity |
NPD1510 |
Phase 2 |
0.8831 |
High Similarity |
NPD1934 |
Approved |
0.8782 |
High Similarity |
NPD3882 |
Suspended |
0.875 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8726 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8704 |
High Similarity |
NPD7054 |
Approved |
0.8675 |
High Similarity |
NPD1511 |
Approved |
0.8654 |
High Similarity |
NPD2801 |
Approved |
0.865 |
High Similarity |
NPD7472 |
Approved |
0.865 |
High Similarity |
NPD7074 |
Phase 3 |
0.8562 |
High Similarity |
NPD1512 |
Approved |
0.8535 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8493 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8485 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8481 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8462 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8434 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.84 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8312 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8293 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8258 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD943 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD2796 |
Approved |
0.821 |
Intermediate Similarity |
NPD919 |
Approved |
0.8199 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8144 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8075 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8075 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD37 |
Approved |
0.8 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD3750 |
Approved |
0.795 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7927 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7904 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7904 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7866 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7824 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7805 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7799 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7799 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7799 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7799 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7785 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7712 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7707 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7702 |
Intermediate Similarity |
NPD920 |
Approved |
0.7688 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7654 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7595 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7584 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7574 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7564 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7558 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7436 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2309 |
Approved |
0.733 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8312 |
Approved |
0.729 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7289 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7225 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7225 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7219 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD7240 |
Approved |
0.719 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7188 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7173 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7076 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7076 |
Intermediate Similarity |
NPD5353 |
Approved |
0.707 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7039 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7013 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7011 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD1608 |
Approved |
0.6993 |
Remote Similarity |
NPD3972 |
Approved |
0.6968 |
Remote Similarity |
NPD1164 |
Approved |
0.6968 |
Remote Similarity |
NPD2797 |
Approved |
0.6963 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD411 |
Approved |
0.6959 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD1357 |
Approved |
0.6952 |
Remote Similarity |
NPD6534 |
Approved |
0.6952 |
Remote Similarity |
NPD6535 |
Approved |
0.6948
|
Remote Similarity |
NPD2983 |
Phase 2 |